Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy
Digestive and Liver Disease(2018)
摘要
Background and aims: Pan-genotypic direct-acting antivirals (DAA) will be the most used regimens. However, their use, in short, ribavirin-free regimens may be affected by the presence of resistance-associated-substitutions (RASs), whose prevalence varies within HCV-genotypes (GTs). This study investigated the resistance profile in HCV 2-3-4 infected, DAA-naïve and DAA-experienced, Italian patients.
更多查看译文
关键词
hcv,infected patients,resistance profiles,daa-experienced
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要